1 / 36

MICR 420

MICR 420. Emerging and Re-Emerging Infectious Diseases Lecture 3: Challenge of Antibiotic Resistance S. aureus (MRSA), E. faecalis (VRE), A. baumannii Dr. Nancy McQueen & Dr. Edith Porter. Challenge of antibiotic resistance S. aureus Methicillin resistance E. faecalis

donovan-rojas
Download Presentation

MICR 420

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MICR 420 Emerging and Re-Emerging Infectious Diseases Lecture 3: Challenge of Antibiotic Resistance S. aureus (MRSA),E. faecalis (VRE), A. baumannii Dr. Nancy McQueen & Dr. Edith Porter

  2. Challenge of antibiotic resistance S. aureus Methicillin resistance E. faecalis Vancomycin resistance A. baumannii MDR Morphology Virulence factors Diseases Diagnosis Culture, biochemicals PCR: toxin production Antibiogram Penicillin binding protein 2a latex agglutination assay Overview

  3. Challenge of Antibiotic Resistance • Antibiotic resistance • Resistance genes • Transfer of resistance genes

  4. Antibiotic Resistance • Enzymes that degrade or modify the antibiotic • b-lactamases • modifying enzymes like acetyltransferases • Alteration of the antibiotic target • Penicillin binding proteins • Inhibition of antibiotic entry • Porin mutations • LPS modifications • Efflux pumps • Tetracycline efflux • Multidrug resistance efflux Funnel connection to an outer membrane channel Pore Central cavity with promiscuous binding site Cell membrane Antibiotic Resistant bacteria are NOT more virulent but they are harder to destroy!

  5. Resistance Genes • Plasmid and chromosomal encoded • E.g., Plasmid: beta-lactams, aminoglycosides • E.g.,Chromosomal: fluoroquinolones, tetracyclines • Spontaneous mutations • At low doses of antibiotics • Acquisition of resistance genes

  6. Acquisition of Resistance Genes • Inherited • Horizontally • Conjugation • Cell to cell contact • Transduction • Virus-mediated • Transformation • Uptake of free DNA Less efficient Occurs also between distantly related genera such as between gram-positive and gram-negative bacteria!

  7. After Stuart B. Levy in “The Challenge of Antibiotic Resistance” Major Causes for Increased Antibiotic Resistance • Improper use in medicine • Incomplete therapy • Inappropriate use for viral infections • Unnecessary use of broad-spectrum antibiotics • Low dose use in animal husbandry to promote animal growth • Use in agriculture leads to unwanted distribution of aerosols

  8. Detection of Antibiotic Resistance • Conventional antibiotic disk diffusion (Kirby Bauer) and determination of minimal inhibitory concentrations • DNA microarrays for detection of plasmid-mediated antimicrobial resistance (and virulence factor) genes

  9. Active Learning Exercise • What role do transposons play in antibiotic resistance?

  10. Staphylococcus aureus

  11. Staphylococcus aureus MSA Agar Plates • Gram positive cocci • In clusters • Facultative anaerobic • Catalase positive • Mannitol positive • Coagulase positive • Often beta-hemolytic • Normal flora (low numbers) • Nostrils • Pharynx • Perineal S. epidermidis S. aureus

  12. S. aureus: Virulence Factors • Coagulase • Various enzymes • Protein A • Binds antibodies via Fc receptor • Various toxins • Enterotoxins • Exfoliative toxin (epidermiolysin) • Toxic shock syndrome toxin Wound Infections Purulent infections Toxin specific diseases

  13. S. aureus Food Intoxication • Uptake of preformed enterotoxin • Nausea, vomiting, diarrhea • Self limited • Short duration

  14. Staphylococcal Exfoliative Toxin: SSSS • Staphylococcal scalded skin syndrome • Cleaves cell adhesion molecules of keratinocytes (desmoglein) (http://dermatlas.med.jhmi.edu/derm/)

  15. First described in menstruating women using certain types of tampons High fever, rash, skin peeling in palms, shock, multiple organ failure Staphylococcus TSST production triggered in these tampons TSST resorption through vaginal mucosa Toxic Shock Syndrome

  16. Toxic Shock Syndrome Pathogenesis • Superantigen mediated • Uncontrolled immune response to staphylococcal and streptococcal toxins • Early signs • Fever • Dizziness • Confusion • Flat red rash over large areas of the body • Shock and multi-organ failure

  17. Superantigens • Activate numerous T Helper cells simultaneously • T Helper cells release numerous proinflammatory cytokines

  18. Bacterial Superantigens • Staphylococcal superantigens • S. aureus • Over 20 described • TSST, exfoliatins, enterotoxins • Streptococcal • S. pyogenes (Group A beta-hemolysing streptococci) • Exotoxin A and C, and others

  19. New Threats by S. aureus • Nosocomial infections (healthcare-associated infections, HAIs) • 15% of all isolates; 8% of all HAIs • Spread of MRSA in the community • Vancomycin resistant MRSA

  20. Methicillin Resistance • High level resistance encoded by MecA • Encodes alternative penicillin binding protein PBP2a • Structural changes in transpeptidase penicillin-binding proteins • Plays role in peptidoglycan synthesis • Low affinity of binding to beta-lactams • Carried by staphylococcal cassette chromosome mec (SCCmec) • Unique mobile genetic element • Integrated into the S. aureus chromosome • Composed of the mec gene complex encoding methicillin resistance and the ccr gene complex that encodes recombinases responsible for its mobility • These elements also carry various resistance genes for non-beta-lactam antibiotics

  21. Spread of MRSA S. aureus in the Community • Adam H et al. • Fatal case of post-influenza, community-associated MRSA pneumonia in an Ontario teenager with subsequent familial transmission. Can Commun Dis Rep. 2007 Feb 15;33(4):45-8. • van der Flier M et al. • Fatal pneumonia in an adolescent due to community-acquired methicillin-resistant Staphylococcus aureus positive for Panton-Valentine-leukocidin. Ned Tijdschr Geneeskd. 2003 May 31;147(22):1076-9. • Francis JS et al. • Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis. 2005 Jan 1;40(1):100-7.

  22. First Reports of Vancomycin Intermediate and Resistant MRSA • Hososaka Y et al. Nosocomial infection of beta-lactam antibiotic-induced vancomycin-resistant Staphylococcus aureus (BIVR). J Infect Chemother. 2006 Aug;12(4):181-4. • Resistance mechanism described for VISA • Sequential point mutations in key global regulatory genes associated predominately with cell wall thickening and restricted vancomycin access to its site of activity in the division septum (Howden et al., 2010)

  23. Enterococcus faecalis

  24. Enterococcus faecalis • Gram positive cocci • In pairs and chains • Catalase negative • Non-hemolytic • Facultative anaerobic • Bile esculin positive • Normal flora in intestine • Often highly resistant to antibiotics • Nosocomial infections • Urinary tract infection • Wound infections • Endocarditis • Vancomycin resistance observed

  25. E. faecalis Virulence factors • Surface protein (ESP) • Adherence • Antiphagocytic • Variations observed • Escapes immune response

  26. Vancomycin Resistant E. faecalis (VRE) • Vancomycin binds to an essential substrate at a late stage of the biosynthetic pathway of peptidoglycan (Reynolds 1989) • D-Ala-D-Ala in peptidoglycan precursor • Vancomycin resistance is caused by the production of depsipeptide D-Ala-D-Lac, which replaces D-Ala-D-Ala (Gin and Zhanel, 1996) • Results in a more-than-1,000-fold lowering of the affinity of vancomycin for its target (Reynolds and Courvalin, 2005).

  27. New Threats by E. faecalis • Spread of VRE in the hospital setting • Zubaidah et al. Hospital-acquired vancomycin-resistant enterococci: now appearing in Kuala Lumpur Hospital. Med J Malaysia. 2006 Oct;61(4):487-9. • Comert et al. First isolation of vancomycin-resistant enteroccoci and spread of a single clone in a university hospital in northwestern Turkey. Eur J Clin Microbiol Infect Dis. 2007 Jan;26(1):57-61. • Vonberg et al. [Prevention and control of the spread of vancomycin-resistant enterococci : Results of a workshop held by the German Society for Hygiene and Microbiology.] Anaesthesist. 2007 Feb;56(2):151-7. • Huang et al. Risk of acquiring antibiotic-resistant bacteria from prior room occupants. Arch Intern Med. 2006 Oct 9;166(18):1945-51. • Bar et al. Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infections due to enterococci. BMC Infect Dis. 2006 Sep 26;6:145. • Furtado et al. Risk factors for vancomycin-resistant Enterococcus faecalis bacteremia in hospitalized patients: an analysis of two case-control studies. Am J Infect Control. 2006 Sep;34(7):447-51.

  28. Acinetobacter baumannii

  29. Acinetobacter baumannii • Pleomorphic gram-negative or gram-variable coccoid rods • Short, fat rods, resemble cocci and diplococci • Can be confused with Neisseria spec. • Non-motile • Non-fermenter • Biofilm production • contributes to antibiotic resistance (Dallo SF, Weitao T 2010) http://www.cyberspaceorbit.com/AB_picenh2.jpg

  30. Threats by Acinetobacter baumannii Outbreaks of infections with carbapenem resistant A. baumannii • Increasingly isolated in hospital settings (war and natural disaster victims) • Wound infections • Septicemia • Increasingly resistant • production of carbapenemases (metallobetalactamases, CRAB) • Worldwide spreading of resistant strains http://www.bioquell.com/Pictures/Acinetobacter%20map.jpg

  31. World Wide Spread of Acinetobacter • Infection. 2010 Apr 1. Successful treatment of three children with post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis. Ozdemir H et al (Turkey) • J Infect Dev Ctries. 2010 Mar 29;4(3):164-7. In vitro antimicrobials activity against endemic Acinetobacter baumannii multiresistant clones. Rodriguez CH et al. (Buonos Aires) • Scand J Infect Dis. 2010 Mar 26. The microbiological characteristics of patients with crush syndrome after the Wenchuan earthquake. Wang T et al. (China) • J Hosp Infect. 2010 Mar 18. Emergence of an extreme-drug-resistant (XDR) Acinetobacter baumannii carrying bla(OXA-23) in a patient with acute necrohaemorrhagic pancreatitis. Grosso F et al. (Portugal) • J Med Assoc Thai. 2009 Dec;92 Suppl 7:S173-80. Clonal spread of carbapenem resistant Acinetobacter baumannii in the patients and their environment at BMA Medical College and Vajira Hospital. Phumisantiphong U et al. (Thailand)

  32. Increasing Nosocomial Infections with Drug Resistant A. baumannii

  33. Take Home Message • Increasing antibiotic resistance is a major threat to public health. • Of particular concern are MRSA, VISA and VRSA, VRE, and A. baumannii. • Antibiotic resistance is mediated by expression of enzymes inactivating the antibiotic, alteration of the drug target, prevention of drug entry into the cell, and drug efflux pumps. • Inappropriate drug use is the major cause.

  34. Resources • Microbiology: An Introduction, by Tortora, Funke and Case; Pearson Prentice Hall; 9th ed, 2007, Chapter 11; pp 436t, 591, 593, 606. 633b • Current Issues: pp 62 -71 • Alekshun MN and Levy SB (2007) Molecular mechanisms of antibacterial multidrug resistance. Cell 128(6):1037-50 • Emerging Infectious Diseases: pp28 – 30 • http://www.microbelibrary.org • CDC fact sheets • http://dermatlas.med.jhmi.edu/derm/ • Hiramatsu K, Cui L, Kuroda M, Ito T. The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol. 2001 Oct;9(10):486-93. • Embedded in slides

More Related